373 related articles for article (PubMed ID: 15885236)
1. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
3. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
5. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
[TBL] [Abstract][Full Text] [Related]
6. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
[TBL] [Abstract][Full Text] [Related]
8. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
Yargui L; Berhoune A
Ann Biol Clin (Paris); 2008; 66(6):657-64. PubMed ID: 19091665
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
Hermida J; Fernández MC; Tutor JC
Clin Lab; 2005; 51(1-2):43-5. PubMed ID: 15719703
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
12. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
Hermida J; Tutor JC
Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
15. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
[TBL] [Abstract][Full Text] [Related]
17. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
[TBL] [Abstract][Full Text] [Related]
18. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.
Barau C; Frangie C; Goujard C; Tribut O; Parant F; Taburet AM; Durrbach A; Furlan V
Ther Drug Monit; 2009 Apr; 31(2):267-8. PubMed ID: 19214146
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650.
Stephen DW; Rooke P; Clark S; Coutts M; Crowe L; Docherty D
Ann Clin Biochem; 2003 Nov; 40(Pt 6):697-700. PubMed ID: 14629812
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
Moscato D; Nonnato A; Adamo R; Vancheri M; Caropreso A
Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]